In line with visual observations, treatment with Gal-9 (300 nM, 24 h) decreased total cell counts in a panel of DLBCL, MCL, Burkitt lymphoma (BL) and follicular lymphoma (FL) cell lines (Figure 1B). Here, LGALS9 is linked to mantle cell lymphoma.